Consumer groups at this week’s FDA advisory panel on general and plastic surgery devices ask the watchdog agency to take Johnson & Johnson breast implants off the market until more safety data can be gathered.
Consumer groups at this week’s FDA advisory panel on general and plastic surgery devices ask the watchdog agency to take Johnson & Johnson breast implants off the market until more safety data can be gathered.